Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00518388 · ClinicalTrials.gov registry record
Perceptions of Cervical Cancer Among Asian Americans
A clinical trial of Epidemiology, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 52
- Enrollment target
- 1
- Study location
NCT00518388: Completed study of Epidemiology, sponsored by M.D. Anderson Cancer Center.
NCT00518388 is a study of Epidemiology that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 52 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00518388, a study of Epidemiology, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to learn about the beliefs, practices, and knowledge about cervical cancer among Asian American young adults. Researchers want to develop materials that will educate Asian Americans about cervical cancer and encourage them to get screened for this disease.
Conditions Studied
Interventions
- BEHAVIORAL Focus Group
- BEHAVIORAL Questionnaire
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2007-08 |
| Est. Completion | 2016-01 |
What the finished NCT00518388 record still lists
NCT00518388 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 1 condition, with Epidemiology appearing as the primary indexed condition, and to 2 interventions - of which Focus Group is the first listed.
NCT00518388 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00518388 about?
NCT00518388 is a clinical study titled "Perceptions of Cervical Cancer Among Asian Americans". The goal of this research study is to learn about the beliefs, practices, and knowledge about cervical cancer among Asian American young adults. Researchers want to develop materials that will educate Asian Americans about cervical cancer and encourage them to get screened for this disease.
What is the current status of trial NCT00518388?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2007-08. Estimated completion is 2016-01.
What conditions does trial NCT00518388 study?
This clinical trial studies the following conditions: Epidemiology.
What interventions are being tested in trial NCT00518388?
The interventions under investigation include: Focus Group (BEHAVIORAL), Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00518388?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00518388 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epidemiology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia